Assessment of renal toxicity induced by sub-chronic zinc nanoparticle administration

Authors

  • Abhivyakti Pathak Department of Veterinary Pathology, G. B. Pant University of Agriculture and Technology, Pantnagar, Uttarakhand Author
  • Seema Agarwal Department of Veterinary Pathology, G. B. Pant University of Agriculture and Technology, Pantnagar, Uttarakhand Author
  • S P Singh Department of Veterinary Pharmacology and Toxicology, G. B. Pant University of Agriculture and Technology, Pantnagar, Uttarakhand Author

DOI:

https://doi.org/10.48165/jvls.2025.1.1.4

Keywords:

Nephrotoxicity, Sub-chronic exposure, Zinc nanoparticles, Wistar rats

Abstract

Zinc nanoparticles (ZnNPs) are increasingly utilized in biomedical, agricultural, and  industrial applications due to their favorable physicochemical properties like melting  point, density, boiling point, viscosity, and solubility. However, their potential for  inducing organ-specific toxicity warrants comprehensive evaluation. This study  aimed to assess the renal toxicity following sub-chronic exposure to ZnNPs in rats.  Thirty-five albino rats were grouped into control (G1) and treated (G2) groups, with  the treated group receiving zinc oxide nanoparticles at the NOAEL dose (31.25 mg/ kg body weight/day) for 90 days. Renal biomarkers, including blood urea nitrogen  (BUN), creatinine, and total protein, were evaluated at 30, 60, and 90 days post treatment (DPT). Significant increases (p<0.05) in creatinine, BUN, and total protein  levels were observed in the treatment group compared to controls at all time points.  Histopathological examination of kidney tissues revealed interstitial hemorrhage,  necrosis of tubular epithelium, leukocytic infiltration, and detachment of tubular  epithelial cells in treated rats, while control animals showed no lesions. These findings  indicate that sub-chronic administration of ZnNPs induces progressive renal damage,  likely mediated by oxidative stress and inflammatory responses. The study underscores  the need for regulatory evaluation and risk assessment of ZnNP exposure to ensure their  safe application in consumer and therapeutic products. 

 

Downloads

Download data is not yet available.

References

Adil, A., Muhammad, F., Ishtiaq, Q., Rashid, S., & Rashid, H. (2025). Nanoparticles as drug delivery vehicles: A comprehensive review on physicochemical properties and biological interactions. Review Journal of Neurological & Medical Sciences, 3(2).

Alqahtani, L. S., Alosaimi, M. E., Abdel-Rahman Mohamed, A., Abd-Elhakim, Y. M., Khamis, T., Noreldin, A. E., El-Far, A. H., Alotaibi, B. S., Hakami, M. A., Dahran, N., & Babteen, N. A. (2024). Acrylamide-targeting renal miR-21a-5p/fibrotic and miR122-5p/inflammatory signaling pathways and role of nano-zinc. Frontiers in Pharmacology, 15, 838–844.

Caiati, C., Arrigoni, R., Stanca, A., & Lepera, M. E. (2025). Kidney toxicity of drugs for the heart: An updated perspective. Metabolites, 15(3), 191–196.

El-Shenawy, F. A., El-Sherbeny, E. M. E., & Kassem, S. (2023). Efficacy of zinc oxide and copper oxide nanoparticles on virulence genes of avian pathogenic E. coli in broilers. BMC Veterinary Research, 19(1), 108–116.

Emeihe, E. V., Nwankwo, E. I., Ajegbile, M. D., Olaboye, J. A., & Maha, C. C. (2024). Nanotechnology-based approaches for targeted drug delivery systems. International Journal of Life Science Research Archive, 7(1), 40–58.

Faddah, L. M., Baky, N. A. A., Al-Rasheed, N. M., Al-Rasheed, N. M., Fatani, A. J., & Atteya, M. (2012). Role of quercetin and arginine in ameliorating nano-zinc oxide-induced nephrotoxicity in rats. BMC Complementary and Alternative Medicine, 12, 1–14.

Goswami, S., Bishnoi, A., Tank, D., Patel, P., Chahar, M., Khaturia, S., Modi, N., Khalid, M., Alam, M. W., Yadav, V. K., & Alreshidi, M. A. (2024). Synthesis, characterization, and applications of zinc oxide nanoparticles: A review. Inorganica Chimica Acta, 122350.

Gulab, H., Fatima, N., Tariq, U., Gohar, O., Irshad, M., Khan, M. Z., Saleem, M., Ghaffar, A., Hussain, M., Jan, A. K., & Humayun, M. (2024). Advances in zinc oxide nanomaterials: Synthesis and applications. Nano-Structures & Nano-Objects, 39, 101271.

Havelikar, U., Ghorpade, K. B., Kumar, A., Patel, A., Singh, M., Banjare, N., & Gupta, P. N. (2024). Mechanisms of nanotoxicity and regulatory challenges of nanomedicines. Discover Nano, 19(1), 165.

Jin, C., Xue, L., Zhang, L., Yu, L., Wu, P., & Qian, H. (2025). Engineered nanoparticles for theranostic applications in kidney repair. Advanced Healthcare Materials, 14(1), 480–488.

Joseph, J., Vemuganti, G. K., Garg, P., & Sharma, S. (2006). Histopathological evaluation of ocular microsporidiosis by different stains. BMC Clinical Pathology, 6, 1–8.

Lebaka, V. R., Ravi, P., Reddy, M. C., Thummala, C., & Mandal, T. K. (2025). Zinc oxide nanoparticles in modern science and technology. Nanomaterials, 15(10), 754.

Meng, Y., Sui, L., Xu, T., Zhao, H., Yuan, Q., & Sun, L. (2025). Nanomedicine in kidney disease: A bibliometric analysis. International Journal of Nanomedicine, 3007–3030.

Min, Y., Suminda, G. G. D., Heo, Y., Kim, M., Ghosh, M., & Son, Y. O. (2023). Metal-based nanoparticles and cytotoxicity mechanisms. Antioxidants, 12(3), 703.

Nag, S., Kar, S., Mishra, S., Stany, B., Seelan, A., Mohanto, S., Kamaraj, C., & Subramaniyan, V. (2024). Green synthesis and biomedical applications of selenium nanoparticles. International Journal of Pharmaceutics, 535–541.

Patel, K. D., Keskin-Erdogan, Z., Sawadkar, P., Sharifulden, N. S. A. N., Shannon, M. R., Patel, M., Silva, L. B., Patel, R., Chau, D. Y., Knowles, J. C., & Perriman, A. W. (2024). Oxidative stress-modulating nanomaterials in nanomedicine. Nanoscale Horizons, 9(10), 1630–1682.

Pathak, A., Agarwal, S., Singh, S. P., Kumar, N., & Verma, M. K. (2022). Hepatotoxicity following zinc nanoparticle exposure in rats. Journal of Veterinary Pharmacology and Toxicology, 21(1), 19–22.

Ramadan, A. G., Yassein, A. A., Eissa, E. A., Mahmoud, M. S., & Hassan, G. M. (2022). Biochemical and histopathological alterations induced by zinc oxide nanoparticles. Journal of Umm Al-Qura University for Applied Sciences, 8(1), 41–49.

Sau, S., Dey, A., Pal, P., Das, B., Maity, K. K., Dash, S. K., Tamili, D. K., & Das, B. (2024). Immunotoxicological role of nanoparticles and therapeutic applications. International Immunopharmacology, 135, 251–257.

Shang, S., Li, X., Wang, H., Zhou, Y., Pang, K., Li, P., Liu, X., Zhang, M., Li, W., Li, Q., & Chen, X. (2024). Targeted therapy of kidney disease using nanoparticle drug delivery systems. Bioactive Materials, 37, 206–221.

Tiwari, H., Gupta, P., Verma, A., Singh, S., Kumar, R., Gautam, H. K., & Gautam, V. (2024). Nanotechnology-based cancer treatment: Advances and concerns. ACS Chemical Health & Safety, 31(2), 153–161.

Umair Hassan, M., Huang, G., Haider, F. U., Khan, T. A., Noor, M. A., Luo, F., Zhou, Q., Yang, B., Ul Haq, M. I., & Iqbal, M. M. (2024). Zinc oxide nanoparticles in mitigating cadmium toxicity. Plants, 13(12), 1706.

Downloads

Published

2025-09-19